(Q35636173)

9 August 2017

Biochemical bone turnover markers and osteoporosis in older men: where are we? (English)

1 reference

9 August 2017

Pawel Szulc

1

1 reference

9 August 2017

15 December 2011

1 reference

9 August 2017

Journal of Osteoporosis

1 reference

9 August 2017

2011

1 reference

9 August 2017

704015

1 reference

Creative Commons Attribution 3.0 Unported

9 August 2017

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246740

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246740

N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246740

Denosumab in men receiving androgen-deprivation therapy for prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246740

Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246740

Biochemical assessment of bone turnover and bone fragility in men.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246740

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246740

Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246740

Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246740

Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246740

Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246740

Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis.

12 July 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Treatment of Isolated Hypogonadotropic Hypogonadism Effect on Bone Mineral Density and Bone Turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Alendronate for osteoporosis in men with androgen-repleted hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Effects of risedronate or alfacalcidol on bone mineral density, bone turnover, back pain, and fractures in Japanese men with primary osteoporosis: results of a two-year strict observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

The effects of three-month intravenous ibandronate on bone mineral density and bone remodeling in Klinefelter's syndrome: the influence of vitamin D deficiency and hormonal status

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Efficacy and safety of monthly ibandronate in men with low bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Prolonged efficacy of a single dose of the bisphosphonate zoledronic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246740

Effects of testosterone replacement in hypogonadal men.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246740

Alendronate for the Treatment of Osteoporosis in Men

25 September 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F704015

High bone turnover in the elderly

21 January 2018

1 reference

12 December 2020

The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients

1 reference

12 December 2020

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

12 December 2020

Determinants of bone loss in elderly men and women: a prospective population-based study

1 reference

12 December 2020

Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease [RETRACTED]

1 reference

12 December 2020

High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over: the prospective MINOS study

1 reference

12 December 2020

Cross-sectional evaluation of bone metabolism in men

1 reference

12 December 2020

Changes in biochemical markers after lower limb fractures

1 reference

12 December 2020

Identifiers

DOI

10.4061/2011/704015

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

PubMed ID

22220284